LASILIX RETARD 60 mg, hard capsule 100 capsules
Active ingredients: Furosemide
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Hard capsule100 capsulesorale
Marketing discontinued
Package details
Original BDPM fields are shown in French.
- Official name
- LASILIX RETARD 60 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 100 gélule(s)
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 22 May 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67131583CIP75566522CIP133400955665229Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUROSÉMIDEgélule | 60 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.